Hudson Bay Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.26M | Hold |
85,000
| – | – | ﹤0.01% | 848 |
|
|
2025
Q4 | $1.36M | Buy |
85,000
+782
| +0.9% | +$11.1K | ﹤0.01% | 764 |
|
|
2025
Q3 | $931K | Sell |
84,218
-19,782
| -19% | -$216K | ﹤0.01% | 871 |
|
|
2025
Q2 | $881K | Buy |
104,000
+4,000
| +4% | +$32.1K | ﹤0.01% | 987 |
|
|
2025
Q1 | $804K | Buy |
100,000
+15,000
| +18% | +$122K | ﹤0.01% | 962 |
|
|
2024
Q4 | $763K | Sell |
85,000
-195,000
| -70% | -$1.59M | ﹤0.01% | 785 |
|
|
2024
Q3 | $2.05M | Sell |
280,000
-59,900
| -18% | -$371K | 0.01% | 565 |
|
|
2024
Q2 | $1.94M | Buy |
339,900
+49,500
| +17% | +$261K | 0.01% | 532 |
|
|
2024
Q1 | $1.45M | Buy |
290,400
+197,900
| +214% | +$1.34M | 0.01% | 504 |
|
|
2023
Q4 | $832K | Sell |
92,500
-63,984
| -41% | -$527K | 0.01% | 533 |
|
|
2023
Q3 | $1.22M | Buy |
156,484
+25,000
| +19% | +$244K | 0.01% | 540 |
|
|
2023
Q2 | $1.27M | Sell |
131,484
-110,000
| -46% | -$1.14M | 0.01% | 556 |
|
|
2023
Q1 | $2.65M | Sell |
241,484
-140,000
| -37% | -$1.23M | 0.02% | 463 |
|
|
2022
Q4 | $1.65M | Buy |
381,484
+66,800
| +21% | +$388K | 0.02% | 626 |
|
|
2022
Q3 | $2.37M | Buy |
314,684
+138,200
| +78% | +$1.2M | 0.02% | 691 |
|
|
2022
Q2 | $1.77M | Buy |
176,484
+15,000
| +9% | +$168K | 0.01% | 827 |
|
|
2022
Q1 | $2M | Buy |
161,484
+61,884
| +62% | +$956K | 0.03% | 695 |
|
|
2021
Q4 | $2.28M | Sell |
99,600
-125,400
| -56% | -$2.97M | 0.02% | 644 |
|
|
2021
Q3 | $4.98M | Sell |
225,000
-410,000
| -65% | -$6.51M | 0.07% | 328 |
|
|
2021
Q2 | $8.23M | Sell |
635,000
-140,000
| -18% | -$1.78M | 0.1% | 184 |
|
|
2021
Q1 | $10.1M | Buy |
775,000
+75,000
| +11% | +$1.09M | 0.12% | 117 |
|
|
2020
Q4 | $9.68M | Buy |
700,000
+145,000
| +26% | +$2.11M | 0.1% | 122 |
|
|
2020
Q3 | $8.18M | Buy |
555,000
+180,000
| +48% | +$2.61M | 0.12% | 141 |
|
|
2020
Q2 | $6.09M | Sell |
375,000
-35,000
| -9% | -$560K | 0.11% | 173 |
|
|
2020
Q1 | $5.95M | Buy |
410,000
+60,000
| +17% | +$1.06M | 0.15% | 125 |
|
|
2019
Q4 | $7.09M | Sell |
350,000
-50,000
| -13% | -$461K | 0.16% | 128 |
|
|
2019
Q3 | $2.14M | Sell |
400,000
-195,000
| -33% | -$1.18M | 0.06% | 248 |
|
|
2019
Q2 | $3.92M | Buy |
595,000
+182,500
| +44% | +$1.16M | 0.09% | 210 |
|
|
2019
Q1 | $2.68M | Buy |
412,500
+137,500
| +50% | +$912K | 0.03% | 411 |
|
|
2018
Q4 | $1.88M | Sell |
275,000
-67,500
| -20% | -$389K | 0.03% | 525 |
|
|
2018
Q3 | $2.27M | Buy |
342,500
+112,500
| +49% | +$631K | 0.03% | 437 |
|
|
2018
Q2 | $1.29M | Sell |
230,000
-70,000
| -23% | -$390K | 0.02% | 597 |
|
|
2018
Q1 | $1.56M | Sell |
300,000
-150,000
| -33% | -$803K | 0.03% | 495 |
|
|
2017
Q4 | $2.04M | Buy |
450,000
+75,000
| +20% | +$416K | 0.04% | 314 |
|
|
2017
Q3 | $2.35M | Buy |
375,000
+25,000
| +7% | +$158K | 0.06% | 230 |
|
|
2017
Q2 | $2.15M | Buy |
+350,000
| New | +$2.36M | 0.04% | 327 |
|
Other funds holding AUPH
TCM
NMC
